King Jim (TSE:7962) has put a stronger set of numbers on the table for Q2 2026, with revenue of ¥9.7b and basic EPS of ¥11.58 as net income reached ¥325.94m for the quarter. The company has seen quarterly revenue move around the ¥8.3b to ¥10.9b range over the past six reported periods, with basic EPS swinging from a loss of ¥10.63 in Q1 2026 to a profit of ¥11.58 in Q2 2026 after periods as low as a loss of ¥7.76 and as high as ¥16.49 since early 2025. This sets up a story where investors are...
Daiichi Sankyo Company (TSE:4568) is back in focus after China approved ENHERTU as the first HER2 directed antibody drug conjugate for second line HER2 positive metastatic gastric cancer. This development spotlights its oncology pipeline alongside recent European regulatory progress.
See our latest analysis for Daiichi Sankyo Company.
Despite the positive headlines around ENHERTU and recent corporate updates, Daiichi Sankyo Company's share price has had a weak patch, with a 30 day share price...
Core (TSE:2359) has put up solid headline numbers for Q3 2026, with revenue of ¥7.0b and basic EPS of ¥63.26, while trailing 12 month EPS stands at ¥201.07 on revenue of ¥26.0b as earnings over that period grew 37.8% year over year. The company has seen revenue move from ¥6.0b in Q2 2025 to ¥6.7b in Q4 2025 and then to ¥7.0b in Q3 2026, with quarterly basic EPS stepping from ¥31.03 to ¥58.59 to ¥63.26 over the same points in time. With net margin at 11.1% over the last year versus 8.5% the...
Nankai Electric Railway (TSE:9044) has put up a clean set of Q3 2026 numbers, with revenue of ¥68,876 million and net income of ¥8,174 million translating into basic EPS of ¥74.9. The company has seen revenue move from ¥63,535 million in Q3 2025 to ¥68,876 million in Q3 2026, while basic EPS has gone from ¥67.7 to ¥74.9 over the same period, giving investors a fuller picture of how the top line and EPS have tracked together. With a trailing net profit margin sitting around 9.1%, the latest...
Hogy MedicalLtd (TSE:3593) has posted Q3 2026 results with revenue of ¥9,862 million and basic EPS of ¥24.63, alongside net income of ¥531 million. The company has seen quarterly revenue move from ¥9,894 million in Q2 2025 to ¥9,862 million in Q3 2026, while basic EPS shifted from ¥39.00 to ¥24.63 over the same span, with net income moving from ¥861 million to ¥531 million. This keeps the focus squarely on how efficiently that revenue is turning into profit.
See our full analysis for Hogy...
Kimura Unity Q3 2026 earnings snapshot
Kimura Unity (TSE:9368) has put fresh numbers on the table for Q3 2026, posting revenue of ¥17.0 billion and net income of ¥1,248 million, which translated into basic EPS of ¥30.35. The company has seen revenue move from ¥15.5 billion in Q3 2025 to ¥17.0 billion in Q3 2026, with EPS shifting from ¥24.74 to ¥30.35 over the same period, while trailing twelve month EPS came in at ¥87.11 on revenue of ¥62.9 billion. With net profit margins running at 5.7%...
Mirai IndustryLtd (TSE:7931) reported Q3 2026 revenue of ¥12.4b and basic EPS of ¥100.07. For recent quarterly context, revenue was ¥11.3b in Q2 2026 and ¥10.1b in Q4 2025, while EPS moved from ¥72.00 to ¥54.95 over those same quarters. The company’s trailing twelve month EPS was ¥290.97 and revenue was ¥45.5b, framing this quarter’s results within a year in which net margin moved from 11.3% to 10.3%, leaving investors to weigh the revenue and EPS figures against slightly softer...
Ichiyoshi Securities (TSE:8624) has put up solid headline numbers for Q3 2026, with revenue of ¥6.6b and net income of ¥1,230m translating into basic EPS of ¥38.36. The company has seen revenue rise from ¥4.72b in Q3 2025 to ¥6.6b in Q3 2026, while basic EPS moved from ¥10.54 to ¥38.36 over the same period, creating a clear earnings-season story focused on scale and profitability. With trailing twelve month EPS at ¥84.01 and a net profit margin that has strengthened, the latest quarter...
Toyo Securities (TSE:8614) has put up a solid set of numbers for Q3 2026, with revenue of ¥3.6 billion and basic EPS of ¥17.71, supported by net income of ¥1.2 billion excluding extra items. The company has seen revenue move from ¥2.6 billion in Q4 2025 to ¥2.8 billion in Q1 2026, ¥3.3 billion in Q2 2026 and now ¥3.6 billion in Q3, while basic EPS has ranged from ¥15.81 to ¥5.30 to ¥16.52 and now ¥17.71 over the same stretch, setting up an earnings story that investors will likely interpret...
Meiji Shipping Group (TSE:9115) has released a mixed but data-rich Q3 2026 update, reporting revenue of ¥15.5b and basic EPS of ¥47.43, set against trailing 12-month EPS of ¥174.11 and net income of ¥5.9b that includes a one-off gain of ¥10.2b. Over recent quarters the company has seen revenue move between ¥15.4b and ¥19.1b, while basic EPS has ranged from a loss of ¥3.88 to a high of ¥85.31. This gives investors a wide band of outcomes to weigh. With net margin at 9.2% versus 5.4% a year...
Juroku Financial GroupInc (TSE:7380) reported Q3 2026 revenue of ¥32,576 million and basic EPS of ¥187.61, with net income of ¥6,705 million. Over the trailing twelve months, revenue came in at ¥138,445 million and EPS was ¥652.99. Over recent quarters the company has seen revenue move between ¥28,920 million in Q2 2025 and ¥37,379 million in Q4 2025, alongside quarterly EPS ranging from ¥113.45 to ¥187.61. This places the latest results within a steadily building earnings profile. With a...
HS Holdings (TSE:8699) has reported Q3 2026 revenue of ¥16,194 million and net income excluding extraordinary items of ¥3,883 million, with basic EPS at ¥129.02, alongside trailing 12 month earnings growth of 15.5% and a net profit margin of 27.4%. Over recent quarters, revenue has moved from ¥9,382 million in Q4 2025 to ¥9,622 million in Q1 2026, ¥15,507 million in Q2 2026 and now ¥16,194 million in Q3, while quarterly EPS has ranged between ¥92.67 and ¥130.08 across this period. For...
Chugai Pharmaceutical (TSE:4519) moved into focus after its board approved proposals for a special year end dividend and higher regular dividends, tying these plans to sustained growth in core net income.
See our latest analysis for Chugai Pharmaceutical.
The special and higher regular dividends come after a strong run in the shares, with a 90 day share price return of 24.85% and a 1 year total shareholder return of 35.25%. The 3 year total shareholder return is very large at around 18x,...
Fujitsu (TSE:6702) has posted Q3 2026 revenue of ¥884.6 billion and basic EPS of ¥46.39, setting the tone for its latest set of numbers. The company has seen quarterly revenue move from ¥924.8 billion in Q3 2025 to ¥884.6 billion in Q3 2026, while basic EPS shifted from ¥28.95 to ¥46.39 over the same period. This gives investors a clear view of how sales and per share earnings are tracking ahead of the full year. With trailing 12 month net profit margins sitting at 8.8%, slightly higher than...
Matsui Securities (TSE:8628) just posted its Q3 2026 scorecard, reporting revenue of ¥12,631 million and basic EPS of ¥17.60, with trailing twelve month revenue at ¥43,764 million and EPS at ¥50.84 providing the backdrop for the latest quarter. The company has seen revenue move from ¥8,961 million and EPS of ¥9.25 in Q3 2025 to ¥12,631 million and EPS of ¥17.60 in Q3 2026. This has occurred alongside trailing twelve month EPS increasing from ¥38.06 in 2024 Q4 to ¥50.84 in 2026 Q3, which puts...